8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      One-year swallowing outcomes following transoral laser microsurgery +/- adjuvant therapy versus primary chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To assess the between-group change in swallowing function from baseline to 12 months following treatment, for patients treated for resectable stage III and IVA oropharyngeal squamous cell carcinoma. To assess the within-group change in swallowing function between 3 and 12 months following treatment.

          Related collections

          Author and article information

          Journal
          Clin Otolaryngol
          Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
          Wiley
          1749-4486
          1749-4478
          Apr 2016
          : 41
          : 2
          Affiliations
          [1 ] Department of Otolaryngology-Head and Neck Surgery, The Freeman Hospital, Newcastle-upon-Tyne, UK.
          [2 ] Institute of Health and Society, Newcastle University, Newcastle, UK.
          [3 ] Department of Speech and Language Therapy, Sunderland Royal Hospital, Sunderland, UK.
          [4 ] Department of Otolaryngology-Head and Neck Surgery, Sunderland Royal Hospital, Sunderland, UK.
          [5 ] Department of Otolaryngology-Head and Neck Surgery, Leeds General Infirmary, Leeds, UK.
          Article
          10.1111/coa.12494
          26135849
          4b2c9a15-1910-4b57-8f2e-15f7f4218095
          © 2015 John Wiley & Sons Ltd.
          History

          Comments

          Comment on this article